Achilles therapeutics to present at upcoming conferences

London, june 12, 2023 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing ai-powered precision t cell therapies to treat solid tumors, today announced that the company will be taking part in the following conferences in june:

ACHL Ratings Summary

ACHL Quant Ranking